Intraocular light scatter in patients on topical intraocular pressure

Abstract

Purpose:

To quantify ocular light scattering in patients under treatment with intraocular pressure–lowering eye-drops.

Methods:

In this prospective, observational, cross-sectional case series study, 160 eyes of 160 patients with primary open angle glaucoma or primary ocular hypertension were consecutively recruited from our Glaucoma Department over 7 months. In total, 46 eyes of 46 healthy volunteers matched for age and sex served as the control group. The variables recorded in a single visit were as follows: drug and number of drops per day, treatment duration, OXFORD corneal staining grade, lower tear meniscus height as measured by spectral domain optical coherence tomography, ocular redness and non-invasive tear breakup time measured with the Oculus Keratograph 5M, ocular surface disease index questionnaire score and objective scatter index through a double-pass technique (Optical Analysis System II).

Results:

Objective scatter index was higher in the patient group (3.1, interquartile range = 1.8–5.47) than in the control group (1.95; interquartile range = 0.7–5; p = 0.017). In a multiple linear regression model, non-invasive tear breakup time was identified as the most influential variable on light scatter (mean ratio = −1.015; p = 0.003; 95% confidence interval = −1.025 to −1.005). No correlation with objective scatter index was observed for number of daily eye-drops, preservative concentration or treatment duration.

Conclusion:

Participants on anti-glaucoma medication showed a significantly higher objective scatter index than control group individuals. In the treated patient group, a lower non-invasive tear breakup time was associated with a higher objective scatter index. This suggests that lubricating eye-drops to improve tear breakup time could also improve vision quality in these patients by diminishing light scattering.

Keywords

Ocular light scattering glaucoma ocular surface disease intraocular pressure–lowering medication

Get full access to this article

View all access options for this article.

References

Allen

Vos

JJ.

Ocular scattered light and visual performance as a function of age. Am J Optom Arch Am Acad Optom 1967; 44(11): 717–727.

Shahidi

Yang

Rajagopalan

et al . A method for differentiating ocular higher-order aberrations from light scatter applied to retinitis pigmentosa. Optom Vis Sci 2005; 82(11): 976–980.

Benito

Pérez

Mirabet

et al . Objective optical assessment of tear-film quality dynamics in normal and mildly symptomatic dry eyes. J Cataract Refract Surg 2011; 37(8): 1481–1487.

Montés-Micó

Role of the tear film in the optical quality of the human eye. J Cataract Refract Surg 2007; 33(9): 1631–1635.

Diaz-Valle

Arriola-Villalobos

García-Vidal

et al . Effect of lubricating eyedrops on ocular light scattering as a measure of vision quality in patients with dry eye. J Cataract Refract Surg 2012; 38(7): 1192–1197.

Ansari

RR.

Ocular static and dynamic light scattering: a noninvasive diagnostic tool for eye research and clinical practice. J Biomed Opt 2004; 9(1): 22–37.

Beckman

Abrahamsson

Sjöstrand

et al . Evaluation of a clinical glare test based on estimation of intraocular light scatter. Optom Vis Sci 1991; 68(11): 881–887.

Fujikado

Kuroda

Maeda

et al . Light scattering and optical aberrations as objective parameters to predict visual deterioration in eyes with cataracts. J Cataract Refract Surg 2004; 30(6): 1198–1208.

Prieto

Vargas-Martín

Goelz

et al . Analysis of the performance of the Hartmann-Shack sensor in the human eye. J Opt Soc Am A Opt Image Sci Vis 2000; 17(8): 1388–1398.

10.

Franssen

Coppens

van den Berg

TJ.

Compensation comparison method for assessment of retinal straylight. Invest Ophthalmol Vis Sci 2006; 47(2): 768–776.

11.

Güell

Pujol

Arjona

et al . Optical quality analysis system; instrument for objective clinical evaluation of ocular optical quality. J Cataract Refract Surg 2004; 30(7): 1598–1599.

12.

Iijima

Shimizu

Kobashi

et al . Repeatability, reproducibility, and comparability of subjective and objective measurements of intraocular forward scattering in healthy subjects. Biomed Res Int 2015; 2015: 925217.

13.

Xue

Wang

et al . Repeatability and reproducibility of a double-pass optical quality analysis device. PLoS ONE 2015; 10(2): e0117587.

14.

De Waard

IJspeert

van

den

Berg

et al . Intraocular light scattering in age-related cataracts. Invest Ophthalmol Vis Sci 1992; 33(3): 618–625.

15.

Artal

Benito

Pérez

et al . An objective scatter index based on double-pass retinal images of a point source to classify cataracts. PLoS ONE 2011; 6(2): e16823.

16.

Henriksen

Kinard

Olson

RJ.

Effect of intraocular lens glistening size on visual quality. J Cataract Refract Surg 2015; 41(6): 1190–1198.

17.

Kamiya

Shimizu

Saito

et al . Comparison of optical quality and intraocular scattering after posterior chamber phakic intraocular lens with and without a central hole (Hole ICL and Conventional ICL) implantation using the double-pass instrument. PLoS ONE 2013; 8(6): e66846.

18.

Xiao

Hao

Zhang

et al . Optical quality of toric intraocular lens implantation in cataract surgery. Int J Ophthalmol 2015; 8(1): 66–71.

19.

Vilaseca

Arjona

Pujol

et al . Optical quality of foldable monofocal intraocular lenses before and after injection: comparative evaluation using a double-pass system. J Cataract Refract Surg 2009; 35(8): 1415–1423.

20.

Lee

Ahn

Kim

et al . Comparison of optical quality parameters and ocular aberrations after wavefront-guided laser in-situ keratomileusis versus wavefront-guided laser epithelial keratomileusis for myopia. Graefes Arch Clin Exp Ophthalmol 2013; 251(9): 2163–2169.

21.

Schmidl

Witkowska

Kaya

et al . The association between subjective and objective parameters for the assessment of dry-eye syndrome. Invest Ophthalmol Vis Sci 2015; 56(3): 1467–1472.

22.

Nanavaty

Stanford

Sharma

et al . Use of the double-pass technique to quantify ocular scatter in patients with uveitis: a pilot study. Ophthalmologica 2011; 225(1): 61–66.

23.

Lee

Sohn

Choi

et al . Optical quality in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 2014; 55(12): 8598–8603.

24.

Kaštelan

Tomić

Metež Soldo

et al . How ocular surface disease impacts the glaucoma treatment outcome. Biomed Res Int 2013; 2013: 696328.

25.

Sezgin Akçay

Bİ

Güney

Bozkurt

et al . Effects of polyquaternium- and benzalkonium-chloride-preserved travoprost on ocular surfaces: an impression cytology study. J Ocul Pharmacol Ther 2014; 30(7): 548–553.

26.

Leung

Medeiros

Weinreb

RN.

Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008; 17(5): 350–355.

27.

Lemp

Baudouin

Baum

et al . The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 75–92.

28.

Chylack

Jr Wolfe

Singer

et al . The lens opacities classification system III. The longitudinal study of Cataract Study Group. Arch Ophthalmol 1993; 111: 831–836.

29.

Mishima

Gasset

Klyce

et al . Determination of tear volume and tear flow. Invest Ophthalmol 1966; 5(3): 264–276.

30.

German

Hurst

Wood

Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?

Eye 1999; 13(Pt 1): 93–100.

31.

Mainstone

Bruce

Golding

TR.

Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res 1996; 15: 653–661.

32.

Shen

Wang

et al . Upper and lower tear menisci in the diagnosis of dry eye. Invest Ophthalmol Vis Sci 2009; 50: 2722–2726.

33.

Bitton

Keech

Simpson

et al . Variability of the analysis of the tear meniscus height by optical coherence tomography. Optom Vis Sci 2007; 84: 903–908.

34.

Zhou

et al . Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study. Ophthalmic Surg Lasers Imaging 2009; 40: 442–447.

35.

Tittler

Bujak

Nguyen

et al . Between-grader repeatability of tear meniscus measurements using Fourier-domain OCT in patients with dry eye. Ophthalmic Surg Lasers Imaging 2011; 42: 423–427.

36.

Arriola-Villalobos

Fernández-Vigo

Díaz-Valle

et al . Assessment of lower tear meniscus measurements obtained with Keratograph and agreement with Fourier-domain optical-coherence tomography. Br J Ophthalmol 2015; 99(8): 1120–1125.

37.

Hong

Tian

et al . Assessment of bulbar redness with a newly developed Keratograph. Optom Vis Sci 2015; 92(8): 892–899.

38.

Anwar

Wellik

Galor

Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol 2013; 24(2): 136–143.

39.

Fechtner

Godfrey

Budenz

et al . Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 2010; 29(6): 618–621.

40.

Schein

Munoz

Tielsch

et al . Prevalence of dry eye among the elderly. Am J Ophthalmol 1997; 124(6): 723–728.

41.

Schiffman

Christianson

Jacobsen

et al . Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118: 615–621.

42.

Walt

Ocular surface disease index (OSDI) administration and scoring manual. Irvine, CA: Allergan, Inc, 2004.

43.

Dougherty

Nichols

KK.

Rasch analysis of the ocular surface disease index (OSDI). Invest Ophthalmol Vis Sci 2011; 52: 8630–8635.

44.

Fasina

Ashaye

Ajayi

BG.

The effect of timolol maleate on tear film break-up time in Nigerians. Afr J Med Med Sci 2008; 37(1): 43–47.

45.

Terai

Muller-Holz

Spoerl

et al . Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects. Clin Ophthalmol 2011; 5: 517–525.

46.

Olthoff

Schouten

van

Borne

et al . Non-compliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 2005; 112: 953–961.

47.

Lan

Lin

Yang

et al . Automatic noninvasive tear breakup time (TBUT) and conventional fluorescent TBUT. Optom Vis Sci 2014; 91(12): 1412–1418.

48.

Alavi

MV.

Aging and vision. Adv Exp Med Biol 2016; 854: 393–399.

49.

Gillespie-Gallery

Binns

et al . Flicker sensitivity in normal aging. Monocular tests of retinal function at photopic and mesopic light levels. Invest Ophthalmol Vis Sci 2016; 57(2): 387–395.

50.

Schwartz

Quigley

HA.

Adherence and persistence with glaucoma therapy. Surv Ophthalmol 2008; 53(Suppl. 1): S57–S68.

51.

Kass

MA.

Compliance and prognosis in glaucoma. Arch Ophthalmol 1985; 103(4): 504.

Intraocular light scatter in patients on topical intraocular pressure–lowering medication